US Patent Issued to China Pharmaceutical University on Oct. 28 for "Aniline-based WDR5 protein-protein interaction inhibitor, and preparation method and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,453,731, issued on Oct. 28, was assigned to China Pharmaceutical University (Jiangsu, China).

"Aniline-based WDR5 protein-protein interaction inhibitor, and preparation method and use thereof" was invented by Qidong You (Nanjing, China), Xiaoke Guo (Nanjing, China), Weilin Chen (Nanjing, China), Dongdong Li (Nanjing, China), Jing Gu (Nanjing, China), Jun Xu (Nanjing, China), Xin Chen (Nanjing, China), Zhengyu Jiang (Nanjing, China) and Xiaoli Xu (Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure discloses a WDR5 protein-protein interaction inhibitor, including a compound having a structure represented by general formul...